Understanding Prenatal Screening Decisions During Pregnancy
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study helps pregnant people make informed choices about genetic screening tests by providing clear, timely information. Researchers want to learn the best way to explain screening options so you can decide what's right for you and your family.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently pregnant and receiving care at UNC Chapel Hill, UCSF General Hospital, or University of Florida Health Jacksonville
- You are 18 years old or older
- You can read, speak, and understand English or Spanish
- You have not yet been offered genetic screening tests for this pregnancy
- You are 24 weeks (6 months) pregnant or less
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, easier-to-understand consent process for mothers who just gave birth. If you join, you will be asked for permission to use a small leftover blood sample from your baby's newborn screening for research purposes.
This study is for pregnant people who were offered prenatal genetic testing. It aims to help them make informed decisions about these tests, with the goal of improving pregnancy outcomes.
This study is testing a chatbot that helps pregnant women think about prenatal genetic tests. You can join if you are early in pregnancy, have a phone or tablet, and haven't already talked to a genetic counselor about this pregnancy.
This study tests a new blood test during early pregnancy that can screen for certain genetic conditions by analyzing fetal cells. A simple blood draw may help detect potential chromosomal abnormalities earlier and more safely than traditional methods.
This study looks at health data from pregnant women to find patterns that could help predict and catch health problems in mothers and babies early. It might offer better monitoring and care during and after pregnancy.
This study tests a decision-support tool (a structured way to guide conversations) for parents facing a high risk of delivering very early (about 22–26 weeks). It may help you and your baby’s care team make clearer, more aligned choices about neonatal (newborn) treatment.
Hear when a new Delivery of Health Care trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.